Blake, Cassels & Graydon LLP utilizes the bench strength of national offices in Toronto, Calgary, Vancouver, Montreal and Ottawa and abroad in London and New York to advise investors, emerging companies and established domestic and multinational corporates across such sectors as e-commerce, tech, agriculture and chemistry, on complex, multi-jurisdictional AI financings and acquisitions, AI risks and regulations and programmes for global data protection compliance in AI systems. The practice is led by Anne Glover, a seasoned litigator and specialist in electronic discovery and information governance; Christopher Jones, a veteran M&A lawyer involved in complex transactions involving AI-based platforms; and Wendy Mee, an expert in data processing and collection matters and privacy considerations related to commercial transactions, litigation and the development of AI tools. All the lawyers mentioned work in the firm's Toronto office.

Legal 500 Editorial commentary

Key clients

  • SandboxAQ
  • Thinktum
  • IAA
  • Wisedocs (formerly Bear Health Technologies)
  • CiteRight
  • GGV Capital
  • Evolve Funds Group Inc.

Work highlights

  • Advised SandboxAQ, a newly formed growth capital AI and quantum computing enterprise in its acquisition of Good Chemistry, a computational chemistry company that leverages AI, Quantum and other technologies to accelerate drug discovery and materials design.
  • Advised Thinktum on its acquisition of the issued and outstanding shares of Illustrate and the assets of Illustrate USA (collectively, "Illustrate").
  • Advised Wisedocs, an artificial intelligence-based platform simplifying medical documentation review, on its C$13m seed equity round, which included Ripple Ventures as lead investor and other angel investors.

Practice head

The lawyer(s) leading their teams.

Anne Glover, Christopher Jones, Wendy Mee